No article text was recorded for this version.
tumor microenvironment reprogramming
Version 2 of 2131 papers177 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Targeting Inhibition of Accumulation and Function of Myeloid-Derived Suppressor Cells by Artemisinin via PI3K/AKT, mTOR, and MAPK Pathways Enhances Anti-PD-L1 Immunotherapy in Melanoma and Liver Tumors
- Blog: Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophages
- Blog: Anti-TGF-β attenuates tumor growth via polarization of tumor associated neutrophils towards an anti-tumor phenotype in colorectal cancer
- Blog: Tumor-specific activation of folate receptor beta enables reprogramming of immune cells in the tumor microenvironment
- Blog: G-CSF Secreted by Epigenetically Reprogrammed Mutant IDH1 Glioma Stem Cells Reverses the Myeloid Cells’-Mediated Immunosuppressive Tumor Microenvironment
- Blog: Oral membrane-biomimetic nanoparticles for enhanced endocytosis and regulation of tumor-associated macrophage
- Blog: The traditional chinese medicine monomer Ailanthone improves the therapeutic efficacy of anti-PD-L1 in melanoma cells by targeting c-Jun
- Blog: The therapeutic effect of thermo-sensitive hydrogel loaded with recombinant mycobacterium smegmatis expressing exogenous IL-15 in abdominal metastasis
- Blog: Hydrogel-Based Vaccines: A Promising Approach for Cancer Immunotherapy
- Blog: De Novo Design and Synthesis of Polypeptide Immunomodulators for Resetting Macrophage Polarization
- Blog: Remodeling tumor microenvironment with natural products to overcome drug resistance
- Blog: Intratumoral Injection of Engineered <i>Mycobacterium smegmatis</i> Induces Antitumor Immunity and Inhibits Tumor Growth
- Blog: Determining M2 macrophages content for the anti-tumor effects of metal-organic framework-encapsulated pazopanib nanoparticles in breast cancer
- Blog: Neoadjuvant with low-dose radiotherapy, tislelizumab, albumin-bound paclitaxel, and cisplatin for resectable locally advanced head and neck squamous cell carcinoma: phase II single-arm trial
- Blog: Clinically friendly smart hydrogel boosts cuproptosis and PD-L1 upregulation to enhance anti-tumor immunotherapy
- Blog: Vascular normalization: reshaping the tumor microenvironment and augmenting antitumor immunity for ovarian cancer
- Blog: A CD8αβ co-receptor modified to contain an intracellular CD28 signaling tail enhances TCR-engineered T cell function independent of solid-tumor-associated co-stimulatory ligands
- Blog: Prognostic Significance of a 9-Gene Signature Related to Tertiary Lymphoid Structures in Male Stomach Adenocarcinoma Patients
- Blog: Humanization of CD47 enables development of functional human neutrophils via postirradiation remodeling of the bone marrow
- Blog: Overcoming immunotherapy resistance in glioblastoma: challenges and emerging strategies
- Blog: Modulation of the immune microenvironment using nanomaterials: a new strategy for tumor immunotherapy
- Blog: Safety and immune cell kinetics after donor natural killer cell infusion following haploidentical stem cell transplantation in children with recurrent neuroblastoma
- Blog: Induction of therapeutic immunity and cancer eradication through biofunctionalized liposome-like nanovesicles derived from irradiated-cancer cells
- Blog: Combined Therapy with Dendritic Cell Loaded-Exosomes Supplemented with PD-1 Inhibition Have Superior Antitumor Effect in Hepatocellular Carcinoma
- Blog: 1232 Decoding the immunologic networks of the AML marrow microenvironment using CODEX
- Blog: A drug screening to identify novel combinatorial strategies for boosting cancer immunotherapy efficacy
- Blog: Application of individualized multimodal radiotherapy combined with immunotherapy in metastatic tumors
- Blog: 1382 DKK1 is a biomarker and immunotherapeutic target for bone metastases in malignant cancers
- Blog: Exploiting innate immunity for cancer immunotherapy
- Blog: Targeted tumor cell-intrinsic CTRP6 biomimetic codelivery synergistically amplifies ferroptosis and immune activation to boost anti-PD-L1 immunotherapy efficacy in lung cancer
- Blog: The traditional Chinese medicine monomer Ailanthone improves the therapeutic efficacy of anti-PD-L1 in melanoma cells by targeting c-Jun
- Blog: Efficacy of immune checkpoint inhibitors combined with bevacizumab in MSS/pMMR advanced colorectal cancer after first-line treatment failure
- Blog: Targeting tumor‑associated macrophages: Critical players in tumor progression and therapeutic strategies (Review)
- Blog: Yeast-derived nanoparticles remodel the immunosuppressive microenvironment in tumor and tumor-draining lymph nodes to suppress tumor growth
- Blog: Combination therapy with oncolytic virus and T cells or mRNA vaccine amplifies antitumor effects
- Blog: 479 Dual blockade of TGF-β and PD-L1 overcomes immune exclusion in HPV-associated cancers
- Blog: Nanomaterials for targeted drug delivery for immunotherapy of digestive tract tumors
- Blog: Harnessing the innate immune system and local immunological microenvironment to treat colorectal cancer
- Blog: Exploration and functionalization of M1-macrophage extracellular vesicles for effective accumulation in glioblastoma and strong synergistic therapeutic effects
- Blog: Antimetastatic Effects of Ganoderma lucidum Polysaccharide Peptide on B16-F10-luc-G5 Melanoma Mice With Sleep Fragmentation
- Blog: Exosomes as drug delivery systems in glioma immunotherapy
- Blog: Immunogenic sonodynamic therapy for inducing immunogenic cell death and activating antitumor immunity
- Blog: Plant-derived Zerumbone and ICG Co-loaded Microneedle Patch System: A Novel Strategy for NIR-triggered Synergistic Chemo-Photothermal Therapy of Melanoma
- Blog: Fn-OMV potentiates ZBP1-mediated PANoptosis triggered by oncolytic HSV-1 to fuel antitumor immunity
- Blog: Tumor-derived extracellular vesicles regulate macrophage polarization: role and therapeutic perspectives
- Blog: Characterization of the impact of daclizumab beta on circulating natural killer cells by mass cytometry
- Blog: Viral‐Directed Augmentation of Kupffer Cell Cross‐Presentation Provokes Antitumor Immunity Against Liver Metastasis
- Blog: The Efficacy and Safety of Sintilimab Combined With Nab-Paclitaxel as a Second-Line Treatment for Advanced or Metastatic Gastric Cancer and Gastroesophageal Junction Cancer
- Blog: Single-Cell Transcriptome Profiling Reveals the Immune Dysregulation Characteristics of Mice Infected With <i>Brucella abortus</i>
- Blog: Immunotherapy for Glioblastoma: Current State, Challenges, and Future Perspectives
- Blog: Tumor targeting peptide TMTP1 modified Antigen capture Nano-vaccine combined with chemotherapy and PD-L1 blockade effectively inhibits growth of ovarian cancer
- Blog: Overexpressed ITGA2 promotes malignant tumor aggression by up-regulating PD-L1 expression through the activation of the STAT3 signaling pathway
- Blog: Engineered exosomes: a promising approach for overcoming challenges in pancreatic cancer therapy
- Blog: Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy
- Blog: Tumor-Associated Macrophages: Recent Insights and Therapies
- Blog: High-dimensional single-cell proteomics analysis of esophageal squamous cell carcinoma reveals dynamic alterations of the tumor immune microenvironment after neoadjuvant therapy
- Blog: In situ vaccination with defined factors overcomes T cell exhaustion in distant tumors
- Blog: Nanovaccines empowering CD8<sup>+</sup> T cells: a precision strategy to enhance cancer immunotherapy
- Blog: Local Exosome Inhibition Potentiates Mild Photothermal Immunotherapy Against Breast Cancer
- Blog: A macrophage-predominant immunosuppressive microenvironment and therapeutic vulnerabilities in advanced salivary gland cancer
Showing 60 of 131 papers.
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_tumor_microenvironment_reprogramming_e6631537,
title = {tumor microenvironment reprogramming},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/tumor-microenvironment-reprogramming/rdr_e663153755a642ab850122fa1efff54a},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}This exact version (version 2, frozen text):
@misc{lacuna_tumor_microenvironment_reprogramming_e6631537_v2,
title = {tumor microenvironment reprogramming},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/tumor-microenvironment-reprogramming/rdr_e663153755a642ab850122fa1efff54a/v/2},
note = {Version 2, frozen 2026-10-04. Accessed 2026-11-19},
}